Abstract
To examine the relative importance of calcium and gastrin in regulation of calcitonin secretion, we administered graded oral doses of calcium to 10 normal men, ages 23-29 yr. Each subject had previously shown an appropriate increase in calcitonin secretion in response to a pharmacologic (0.5 μg/kg) pentagastrin injection. On separate days and in random order, each man drank 250 ml of distilled water containing 0.0, 0.5, 1.5, and 3.0 g of elemental calcium as the gluconate salt. Blood samples were drawn before and at 30, 60, 90, 120, 180, and 240 min after the oral calcium dose. The samples were analyzed for calcium by atomic absorption spectroscopy, and for gastrin and calcitonin by radioimmunoassays of established sensitivity and specificity. Ingestion of water (control) caused no change in any of the three variables. Calcium ingestion resulted in dose-related increases, within the normal range, of all three variables. Immunoreactive gastrin rose promptly, peaking at 30 min, and returning to basal levels or below by 120 min. In contrast, calcium and immunoreactive calcitonin levels rose slowly and in parallel, peaking at 120-240 min. Changes in calcitonin and changes in calcium were strongly and positively correlated, r = 0.73, when all data were pooled. Furthermore, individual linear regressions for changes in calcitonin and calcium levels (calculated separately for the three oral calcium doses in each subject) had positive slopes in 28 out of 30 sets (P < 0.01). The changes in calcitonin concentrations were much more poorly correlated with the corresponding changes in serum gastrin levels; in fact, the regression coefficient was weakly negative, r = −0.20. These results show that, at least in young adult men, changes of ambient calcium concentration within the normal range may be of major importance in physiologic regulation of calcitonin secretion. The findings are consistent with the hypothesis that calcitonin functions to prevent excessive postprandial hypercalcemia.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Care A. D., Bates R. F., Swaminathan R., Ganguli P. C. The role of gastrin as a calcitonin secretagogue. J Endocrinol. 1971 Dec;51(4):735–744. doi: 10.1677/joe.0.0510735. [DOI] [PubMed] [Google Scholar]
- Cooper C. W., Hirsch P. F., Munson P. L. Importance of endogenous thyrocalcitonin for protection against hypercalcemia in the rat. Endocrinology. 1970 Feb;86(2):406–415. doi: 10.1210/endo-86-2-406. [DOI] [PubMed] [Google Scholar]
- Gray TKMUNSON P. L. Thyrocalcitonin: evidence for physiological function. Science. 1969 Oct 24;166(3904):512–513. doi: 10.1126/science.166.3904.512. [DOI] [PubMed] [Google Scholar]
- Heath H., 3rd, Sizemore G. W. Plasma calcitonin in normal man. Differences between men and women. J Clin Invest. 1977 Nov;60(5):1135–1140. doi: 10.1172/JCI108865. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Heynen G., Franchimont P. Human calcitonin radioimmunoassay in normal and pathological conditions. Eur J Clin Invest. 1974 Jun;4(3):213–222. doi: 10.1111/j.1365-2362.1974.tb00395.x. [DOI] [PubMed] [Google Scholar]
- Owyang C., Heath H., 3rd, Sizemore G. W., Go V. L. Comparison of the effects of pentagastrin and meal-stimulated gastrin on plasma calcitonin in normal man. Am J Dig Dis. 1978 Dec;23(12):1084–1088. doi: 10.1007/BF01072883. [DOI] [PubMed] [Google Scholar]
- Parthemore J. G., Deftos L. J. Calcitonin secretion in normal human subjects. J Clin Endocrinol Metab. 1978 Jul;47(1):184–188. doi: 10.1210/jcem-47-1-184. [DOI] [PubMed] [Google Scholar]
- Sizemore G. W., Go V. L., Kaplan E. L., Sanzenbacher L. J., Holtermuller K. H., Arnaud C. D. Relations of calcitonin and gastrin in the Zollinger-Ellison syndrome and medullary carcinoma of the thyroid. N Engl J Med. 1973 Mar 29;288(13):641–644. doi: 10.1056/NEJM197303292881301. [DOI] [PubMed] [Google Scholar]